VLPCOV-02

N/A

Report date: 2026/05/12 09:17:27

Base Information

Drug NameVLPCOV-02

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine > self-amplifying mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVlp Therapeutics Llc

China Registration ClassN/A

Develop Information

Active CompaniesVlp Therapeutics Llc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A